Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.

A team of scientists at the University of Toronto have successfully implemented AI tools to speed up the process of ...

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

XtalPi Holdings, an artificial intelligence (AI) drug discovery firm based in the Greater Bay Area, is changing the ...

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

Drugmakers, academics and logistics professionals are using artificial intelligence to address the industry’s most pressing ...

Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to ...

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

VALID, a Techbio startup dedicated to reshaping drug discovery with complex human induced pluripotent stem cell (iPSC) co-culture models that deliver increased predictive validity, has partnered with ...